In vivo and in vitro Effects of Ghrelin/Motilin-Related Peptide on Growth Hormone Secretion in the Rat
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Ghrelin (Ghr), a 28 amino acid gastric peptide with an n-octanoylation on Ser 3, has recently been identified as an endogenous ligand of the growth hormone secretagogue (GHS) receptor. A cDNA was also isolated from a mouse stomach library encoding a protein named prepromotilin-related peptide (ppMTLRP) which shares sequence similarities with prepromotilin. Mouse and rat ppMTLRP sequences (rGhr) are identical and show 89% identity with human ghrelin (hGhr). By analogy with promotilin, cleavage of proMTLRP into an 18 amino acid endogenous processed peptide can be assumed on the basis of a conserved dibasic motif in position 9–10 of its sequence. In the present work, we compared the GH-releasing activity of rGhr28/MTLRP and of hGhr28/MTRLP with that of a shorter form of the peptide, hGhr18. A short peptide devoid of Ser-3 n-octanoylation hGhr18[–] was also tested. Addition of rGhr28, hGhr28 and hGhr18 stimulated GH release to the same extent from superfused pituitaries. The effect was dose dependent in a 10–8 to 10–6M concentration range. In contrast, hGhr 18[–] was inactive. In freely moving animals, both rGhr28 and hGhr28 (10 µg, i.v.) stimulated GH release, whereas the same dose of hGhr18 or of hGhr18[–] was ineffective. After rGhr28, GH plasma levels increased as early as 5 min after injection and returned to basal values within 40–60 min. Expressed as percent stimulation, administration of rGhr28 was equally effective when injected during troughs or peaks of GH. Plasma concentrations of prolactin, adrenocorticotropin and leptin were not modified. Spontaneous GH secretory episodes were no longer observed within 3 h of rGhr28 treatment, but repeated administration of the secretagogue at 3- to 4-hour intervals resulted in a similar GH response. Activation of somatostatin (SRIH) release by ether stress did not blunt the GH response to rGhr28. This suggests that the secretagogue acts in part by inhibiting endogenous SRIH, as further substantiated by the ability of rGhr28 (10–6M), to decrease the amplitude of 25 m M K+-induced SRIH release from perifused hypothalami. In conclusion, (1) n-octanoylation of Ghrs and the shorter form hGhr18 is essential for the direct pituitary GH-releasing effect of this new family of endogenous GHSs; (2) only the longer forms are active in vivo and (3) inhibition of SRIH release appears involved in the mechanism of Ghr action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Ghrelin induces adiposity in rodents
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949
Cited by
Plasma Ghrelin Levels in Lean and Obese Humans and the Effect of Glucose on Ghrelin Secretion
Shiiya, T., Nakazato, M., Mizuta, M., Date, Y., Mondal, M. S., Tanaka, M., Nozoe, S.-I., Hosoda, H., Kangawa, K., & Matsukura, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.240 · Cited by 1,299
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
van der Lely, A. J., Tschöp, M., Heiman, M. L., & Ghigo, E. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0029 · Cited by 1,187
Ghrelin?a hormone with multiple functions
KORBONITS, M. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.03.002 · Cited by 595
Minireview: Ghrelin and the Regulation of Energy Balance--A Hypothalamic Perspective
Horváth, T. L., Diano, S., Sótonyi, P., Heiman, M. L., & Tschöp, M. H. (2001) · Endocrinology · doi:10.1210/en.142.10.4163 · Cited by 567
Ghrelin: An orexigenic and somatotrophic signal from the stomach
Inui, A. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086018 · Cited by 396
Tolle, V., Kadem, M., Bluet-Pajot, M.-T., Frere, D., Foulon, C., Bossu, C., Dardennes, R., Mounier, C., Zizzari, P., Lang, F., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020645 · Cited by 356
Self-citationDose-Dependent Inhibition by Ghrelin of Insulin Secretion in the Mouse
Reimer, M. K., Pacini, G., & Ahrén, B. (2003) · Endocrinology · doi:10.1210/en.2002-220819 · Cited by 316
Tolle, V. (2002) · Endocrinology · doi:10.1210/en.143.4.1353 · Cited by 310
Self-citationSaito, E.-S., Kaiya, H., Tachibana, T., Tomonaga, S., Denbow, D. M., Kangawa, K., & Furuse, M. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.09.003 · Cited by 303
Ghrelin promotes slow-wave sleep in humans
Weikel, J. C., Wichniak, A., Ising, M., Brunner, H., Friess, E., Held, K., Mathias, S., Schmid, D. A., Uhr, M., & Steiger, A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00184.2002 · Cited by 291
Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion
Egido, E., Rodriguez-Gallardo, J., Silvestre, R., & Marco, J. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460241 · Cited by 275
Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat
Trudel, L., Tomasetto, C., Rio, M. C., Bouin, M., Plourde, V., Eberling, P., & Poitras, P. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00339.2001 · Cited by 274
Self-citationGumbs, A. A., Modlin, I. M., & Ballantyne, G. H. (2005) · Obesity Surgery · doi:10.1381/0960892053723367 · Cited by 188
Feng, D. D., Yang, S.-K., Loudes, C., Simon, A., Al-Sarraf, T., Culler, M., Alvear-Perez, R., Llorens-Cortes, C., Chen, C., Epelbaum, J., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07787.x · Cited by 41
Self-citation
Metadata
- Authors
- Tolle, V., Zizzari, P., Tomasetto, C., Rio, M.-C., Epelbaum, J., & Bluet-Pajot, M.-T.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2001
- Volume
- 73
- Issue
- 1
- Pages
- 54-61
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W1983916563
- Cited by
- 173
- References
- 2
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.